Aditya Singh Opposition, Bictegravir / Emtricitabine / Tenofovir Alafenamide, (201817013772)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Delhi Network of Positive People opposition, Lenacapavir, (201917006277)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017010006)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017007904)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (7440/DELNP/2015)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202018020805)
Countries: India Date: 2021
-
LOW COST STANDARD THERAPEUTICS opposition, TAF/FTC, (201817001590)
Countries: India Date: 2023
-
Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (3383/DELNP/2005)
Countries: India Date: 2009
-
Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate tenofovir disoproxil fumarate (TDF) , (1135/DEL/2007 (divisional to 896/DEL/2002))
Countries: India Date: 2012
-
Gujarat State Network of People Living with HIV/AIDS opposition, Tenofovir Alafenamide Fumarate , (568/MUMNP/2011)
Countries: India Date: 2015
-
Amrita Majumdar opposition, Tenofovir Alafenamide Fumarate , (568/MUMNP/2011)
Countries: India Date: 2015